Predicting developmental toxicity through toxicogenomics

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 90, Issue 2, 2010, Pages 110-117

  Daston, George P ^a   Naciff, Jorge M ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Predictive toxicology; Systems toxicology; Toxicogenomics

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CYSTATIN B; ESTROGEN; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; GENISTEIN; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA; MICRORNA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHYTOESTROGEN; PROGESTERONE RECEPTOR; RETINOL BINDING PROTEIN; SOMATOMEDIN C; TYROSINE KINASE RECEPTOR;

ANGIOGENESIS; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; DOSE RESPONSE; DRUG INDUSTRY; ENDOMETRIUM CARCINOMA; ESTRUS; EXPOSURE; FATTY ACID METABOLISM; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LEUKEMIA; LIFE CYCLE; LIVER TOXICITY; MELANOMA; MICROARRAY ANALYSIS; NONHUMAN; OVARY; PHENOTYPE; PREDICTION AND FORECASTING; PREDICTOR VARIABLE; PREPUBERTY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STEROID METABOLISM; TARGET CELL; TARGET ORGAN; TESTIS; TOXICOGENETICS; TOXICOLOGY; UTERUS;

ANIMALS; ESTROGENS; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION; HAZARDOUS SUBSTANCES; HUMANS; MALE; PERCIFORMES; RATS; RISK ASSESSMENT; SHEEP; TOXICOGENETICS;

ANIMALIA;

EID: 77953530648     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20178     Document Type: Review

References (41)

1. Ansieau S, Bastid J, Doreau A, et al. 2008. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14:79-89.
2. Bucco RA, Zheng WL, Wardlaw SA, et al. 1996. Regulation and localization of cellular retinol-binding protein, retinol-binding protein, cellular retinoic acid-binding protein (CRABP), and CRABP II in the uterus of the pseudopregnant rat. Endocrinology 137:3111-3122. (Pubitemid 126425502)
3. Chengalvala MV, Chennathukuzhi VM, Johnston DS, et al. 2007. Gene expression profiling and its practice in drug development. Curr Genomics 8:262-270.
4. Daston GP. 2007. Genomics and developmental risk assessment. Birth Defects Res A Clin Mol Teratol 79:1-7.
5. Daston GP, Naciff JM. 2005. Gene expression changes related to growth and differentiation in the fetal and juvenile reproductive system of the female rat: evaluation of microarray results. Reprod Toxicol 19:381-394.
6. Diel P, Schulz T, Smolnikar K, et al. 2000. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol 73:1-10.
7. Eberhardt DM, Jacobs WG, Godkin JD. 1999. Steroid regulation of retinol-binding protein in the ovine oviduct. Biol Reprod 60:714-720.
8. Eyre LJ, Rabbitt EH, Bland R, et al. 2001. Expression of 11β-hydroxysteroid dehydrogenase in rat osteoblastic cells: pre-receptor regulation of glucocorticoid responses in bone. J Cell Biochem 81:453-462.
9. Fielden MR, Halbert DN. 2007. Iconix Biosciences, Inc. Pharmacogenomics 8:401-405.
10. Fielden MR, Pearson C, Brennan R, Kolaja KL. 2005. Preclinical drug safety analysis by chemogenomic profiling in the liver. Am J Pharmacogenomics 5:161-171.
11. Funkenstein B. 2001. Developmental expression, tissue distribution and hormonal regulation of fish (Sparus aurata) serum retinol-binding protein. Comp Biochem Physiol B Biochem Mol Biol 129:613-622.
12. Gitelman I. 2007. Evolution of the vertebrate twist family and synfunctionalization: a mechanism for differential gene loss through merging of expression domains. Mol Biol Evol 24:1912-1925.
13. Gong XQ, Li L. 2002. Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. J Biol Chem 277:12310-12317.
14. Gwinn MR, Weston A. 2008. Application of oligonucleotide microarray technology to toxic occupational exposures. J Toxicol Environ Health A 71:315-324.
15. Hirode M, Ono A, Miyagishima T, et al. 2008. Gene expression profiling in rat liver treated with compounds inducing phospholipidosis. Toxicol Appl Pharmacol 229:290-299.
16. Kraus WL, Montano MM, Katzenellenbogen BS. 1993. Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters. Mol Endocrinol 7:1603-1616. (Pubitemid 124005041)
17. Krisinger J, Dann JL, Currie WD, et al. 1992. Calbindin-D9k mRNA is tightly regulated during the estrous cycle in the rat uterus. Mol Cell Endocrinol 86:119-123.
18. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. 2007. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 313:1929-1935.
19. Lau C, Mole ML, Copeland MF, et al. 2001. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data. Toxicol Sci 59:37-48. (Pubitemid 32117979)
20. L'Horset F, Perret C, Brehier A, Thomasset M. 1990. 17 Beta-estradiol stimulates the calbindin-D9k (CaBP9k) gene expression at the transcriptional and posttranscriptional levels in the rat uterus. Endocrinology 127:2891-2897.
21. Liu K, Lehmann KP, Sar M, Young SS, Gaido KW. 2005. Gene expression profiling following in utero exposure to phthalate esters reveals new gene targets in the etiology of testicular dysgenesis. Biol Reprod. 73:180-92.
22. Melnick R, Lucier G, Wolfe M, et al. 2002. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect 110:427-431.
23. Naciff JM, Daston GP. 2004. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity. Toxicol Pathol 32 (Suppl 2):59-70.
24. Naciff JM, Jump ML, Torontali SM, et al. 2002. Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 68: 184-199.
25. Naciff JM, Overmann GJ, Torontali SM, et al. 2003. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci 72:314-330.
26. Naciff JM, Richardson BD, Oliver KG, et al. 2005a. Design of a microsphere- based high-throughput gene expression assay to determine estrogenic potential. Environ Health Perspect 113:1164-1171.
27. Naciff JM, Hess KA, Overmann GJ, et al. 2005b. Gene expression changes induced in the testis by transplacental exposure to high and low doses of 17{alpha}-ethynyl estradiol, genistein, or bisphenol A. Toxicol Sci 86:396-416.
28. Naciff JM, Torontali SM, Overmann GI, et al. 2005c. Evaluation of the gene expression changes induced by 17- alpha-ethynyl estradiol in the immature uterus/ovaries of the rat using high density oligonucleotide arrays. Birth Defects Res B Dev Reprod Toxicol 74:164-184.
29. Naciff JM, Overmann GJ, Torontali SM, et al. 2007. Uterine temporal response to acute exposure to 17alpha-ethinyl estradiol in the immature rat. Toxicol Sci 97:467-490.
30. Naciff JM, Khambatta ZS, Thomason RG, Carr GJ, Tiesman JP, Singleton DW, Khan SA, Daston GP. 2009. The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 107:40-55.
31. Nagel SC, vom Saal FS, Thayer KA, et al. 1997. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 105:70-76.
32. Noda S, Sawaki M, Shiraishi K, et al. 2002. Age-related changes of genital systems in the female Crj:CD (SD) IGS rats during sexual maturation. J Vet Med Sci 64:315-319. (Pubitemid 135746724)
33. NRC 2008. Science and decisions: advancing risk assessment. Washington, DC: National Academies Press.
34. Putz O, Schwartz CB, LeBlanc GA, et al. 2001. Neonatal low- and high-dose exposure to estradiol benzoate in the male rat. II. Effects on male puberty and the reproductive tract. Biol Reprod 65:1506-1517.
35. Rivera-Gonzales RT, Petersen DN, Tkalcevic G, et al. 1998. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen. J Steroid Biochem Mol Biol 64:13-24.
36. Sahlin L, Eriksson H. 1996. Influence of blockers for the estrogen receptor (ER) and type 1 IGF-receptor on the levels of ER, ER mRNA and IGF-I mRNA in the rat uterus. J Steroid Biochem Mol Biol 58:359-365.
37. Sahlin L, Elger W, Akerberg S, et al. 2000. Effects of estradiol and estradiol sulfamate on the uterus of ovariectomized or ovariectomized and hypophysectomized rats. J Steroid Biochem Mol Biol 74:99-107.
38. Sato S, Shirakawa H, Tomita S, et al. 2008. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol Appl Pharmacol 229:10-19.
39. Tamura M, Noda M. 1999. Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. J Cell Biochem 72:167-176.
40. Waters KM, Safe S, Gaido KW. 2001. Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. Toxicol Sci 63:47-56.
41. Wills Q. 2007. SimuGen Ltd: reliable, early prediction of drug toxicity with toxicogenomics, human cell culture and computational models. Pharmacogenomics 8:1081-1084.